Radiopharmacokinetics of radioiodine in the parotid glands after the administration of lemon juice

Thyroid

Volumn 20, Issue 10, 2010, Pages 1113-1119

  Van Nostrand, Douglas ^a   Bandaru, Varalakshmi ^a   Chennupati, Shyam ^a   Wexler, Jason ^a   Kulkarni, Kanchan ^a   Atkins, Frank ^a   Mete, Mihriye ^b   Gadwale, Gurudev ^b  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b MEDSTAR HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 123; IODINE 131;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG ACCUMULATION; FEMALE; FOOD DRUG INTERACTION; HUMAN; LEMON JUICE; MALE; PAROTID GLAND; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIOACTIVITY; RADIOISOTOPE DISTRIBUTION; RETROSPECTIVE STUDY; SALIVARY GLAND SCINTISCANNING;

ADULT; AGED; BEVERAGES; CITRUS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PAROTID GLAND; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SIALADENITIS; THYROID NEOPLASMS;

EID: 77957914619     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.0429     Document Type: Article

References (12)

1. Kloos RT 2009 Protecting thyroid cancer patients from untoward effects of radioactive iodine treatment. Thyroid 19:925-928.
2. Mandel SJ, Mandel L 2003 Radioactive iodine and the salivary glands. Thyroid 13:265-271.
3. Van Nostrand D, Freitas J 2006 Side effects of 131-I for ablation and treatment of well-differentiated thyroid carcinoma. In: Wartofsky L, Van Nostrand D (eds) Thyroid Cancer: A Comprehensive Guide to Clinical Management. Humana Press, Totowa, NJ, pp 459-484.
4. Nakada K, Ishibashi T, Takei T, Hirata K, Shinohara K, Katoh S, Zhao S, Tamaki N, Noguchi Y, Noguchi S 2005 Dose lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer? J Nucl Med 46:261-266.
5. Lam MGEH, van Isselt JW 2005 Does lemon candy decreased salivary gland damage after radioiodine therapy for thyroid cancer? Letter to the editor. J Nucl Med 46:2118-2119.
6. Silberstein EB 2008 Reducing the incidence of 131-I-induced sialadenitis: the role of pilocarpine. J Nucl Med 49:546-549.
7. Van Nostrand D, Atkins F, Bandaru VV, Chennupati SP, Moreau S, Burman K, Wartofsky L 2009 Salivary gland protection with sialagogues. A case report. Thyroid 19:1005-1008.
8. Liu B, Kuang A, Huang R, Zhao Z, Zeng Y, Wang J, Tian R 2010 Influence of vitamin C on salivary absorbed dose of 131-I in thyroid cancer patients; a prospective, randomized, single-blind, controlled trail. J Nucl Med 51:618-623.
9. Harden RM, Alexander WD, Shimmins J, Chisholm D 1969 A comparison between the gastric and salivary concentration of iodide, pertechnetate, and bromide in man. Gut 10:928-930.
10. Honour AJ, Myant NB, Rowlands EN 1952 Secretion of radioiodine in digestive juices and milk in man. Clin Sci 11:447-462.
11. Zuckier LS, Dohan O, Li Y, Chang CJ, Carrasco N, Dadachova E 2004 Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate and iodide by NaI symporter-expressing tissues in vivo. J Nucl Med 45:500-507.
12. Van Nostrand D, Atkins F, Yeganeh F, Acio E, Bursaw R, Wartofsky L 2002 Dosimetrically determined doses of radioiodine for the treatment of metastatic thyroid carcinoma. Thyroid 12:121-134.